United Therapeutics competitors

Yvonne Greenstreet is a COO at ALNYLAM PHARMACEUTICALS, INC..

Jean-Jacques Bienaime is a Board Member at Biotechnology Innovation Organization - BIO, Director at INCYTE CORP, and Chairman/CEO at BioMarin Pharmaceutical Inc and is based in Novato, California. He has experience at Rhône Poulenc Rorer and has worked as President/CEO at GENENCOR INTERNATIONAL INC, Board Member at NeurogesX Inc, and Marketing Director at Genentech. Jean attended ESCP Europe, Ecole Superieure de Commerce de Paris between 1974 and 1976, and University of Pennsylvania.

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Reshma Kewalramani (born 1973), is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.

Richard 'Rich' Mott is a Chairman at Conventus Orthopaedics Inc, President/CEO at Kyphon, and Board Member at Vertiflex. He has worked as Board Member at Alfred University, Board Member at Conventus Orthopaedics Inc, and VP/General Manager at Greatbatch Scientific. Richard attended Alfred University and Harvard University.

Tony Balda has dedicated over 15 years to the healthcare and med-tech industry. He has been Chief Executive Officer of Medicomp since 2014. Tony is responsible for day-to-day business operations, the organization’s strategic advancement in the marketplace, as well as the growth and development. Prior to Medicomp, Tony was VP of Marketing and Strategy for the Telemedicine division of United Therapeutics. Tony earned his MBA from Wharton and his BA in applied Economics and management from Cornell University.

Stéphane Bancel (born 1972) is a French billionaire businessman. He is the chief executive officer (CEO) and a 9% owner of Moderna, an American biotechnology company.